152 related articles for article (PubMed ID: 36037128)
1. Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia.
Hussein S; Abdelazem AS; Abdelmoneem S; Abdelnabi AM; Khamis T; Obaya AA; Ebian HF
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2735-2742. PubMed ID: 36037128
[TBL] [Abstract][Full Text] [Related]
2. Expression of
Plešingerová H; Janovská P; Mishra A; Smyčková L; Poppová L; Libra A; Plevová K; Ovesná P; Radová L; Doubek M; Pavlová Š; Pospíšilová Š; Bryja V
Haematologica; 2018 Feb; 103(2):313-324. PubMed ID: 29122990
[TBL] [Abstract][Full Text] [Related]
3. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
4. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia.
Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
[No Abstract] [Full Text] [Related]
5. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
[TBL] [Abstract][Full Text] [Related]
6. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
7. Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia.
Aghebati-Maleki L; Shabani M; Baradaran B; Motallebnezhad M; Majidi J; Yousefi M
Biomed Pharmacother; 2017 Apr; 88():814-822. PubMed ID: 28160756
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case-control study.
Davari N; Ahmadpour F; Kiani AA; Azadpour M; Asadi ZT
BMC Res Notes; 2021 Jan; 14(1):21. PubMed ID: 33430952
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia.
Yikilmaz AŞ; Bakanay ŞM; Avcı DN; Akinci S; Falay M; Özet G; Dilek İ
Int J Hematol Oncol Stem Cell Res; 2023 Jan; 17(1):39-47. PubMed ID: 37638287
[No Abstract] [Full Text] [Related]
10.
Balatti V; Tomasello L; Rassenti LZ; Veneziano D; Nigita G; Wang HY; Thorson JA; Kipps TJ; Pekarsky Y; Croce CM
Blood; 2018 Nov; 132(20):2179-2182. PubMed ID: 30242085
[TBL] [Abstract][Full Text] [Related]
11. Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.
Han SH; Kim SH; Kim HJ; Lee Y; Choi SY; Park G; Kim DH; Lee A; Kim J; Choi JM; Kim Y; Myung K; Kim H; Kim DW
Leukemia; 2017 Jul; 31(7):1532-1539. PubMed ID: 28232743
[TBL] [Abstract][Full Text] [Related]
12. [mRNA Expressions of T-bet, GATA-3, ROR γt and Foxp3 in peripheral blood of patients with chronic lymphocytic leukemia in different stages].
Yu JJ; Chen G; Pang NN; Guo XH; Wang L; Zhao F; Tan MF; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):45-9. PubMed ID: 25687044
[TBL] [Abstract][Full Text] [Related]
13. miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes.
Fotoh DS; Noreldin RI; Rizk MS; Elsabaawy MM; Esaily HA
J Immunol Res; 2020; 2020():2180913. PubMed ID: 33426087
[TBL] [Abstract][Full Text] [Related]
14. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-125a-3p expression in abdominal adipose tissues is associated with insulin signalling gene expressions in morbid obesity: observations in Taiwanese.
Yeh CL; Cheng IC; Hou YC; Wang W; Yeh SL
Asia Pac J Clin Nutr; 2014; 23(2):331-7. PubMed ID: 24901105
[TBL] [Abstract][Full Text] [Related]
16. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
17. Prognosis biomarkers evaluation in chronic lymphocytic leukemia.
Gomes LC; Evangelista FCG; Sousa LP; Araujo SSDS; Carvalho MDG; Sabino AP
Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):57-62. PubMed ID: 28183684
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
19. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
20. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia.
Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M
Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
